5-HT2A is one of major serotonin receptor that is involved in the action of serotonin-targeting drugs. Previous clinical studies have shown an unexpected association between lower cholesterol level and psychiatric diseases, in which T102C polymorphism of HTR2A, gene of 5-HT2A serotonin receptor, might be involved. Therefore, we hypothesized a potential association between lower cholesterol level and T102C polymorphism. The effect of the T102C polymorphism on the serum lipid profiles of 646 subjects without specific psychiatric disease was investigated. Genotype was determined by polymerase chain reaction and restriction fragment length polymorphism analysis. There were significantly lower levels of total cholesterol (193.6 ± 35.0 versus 202.1 ± 45.5 mg/dl, p = 0.016) and HDL-cholesterol (42.7 ± 11.6 versus 46.3 ± 12.7 mg/dl, p = 0.004) in CC genotype than non-CC genotypes. Moreover, multivariate analysis showed that the CC genotype is a strong predictor of a lower HDL-cholesterol level (p < 0.001). In conclusion, this study shows that the CC genotype of the HTR2A gene is related to lower HDL-cholesterol level in Koreans. This is the first demonstration showing the potential genetic relationship between the serotonin receptor gene polymorphism and the HDL-cholesterol level.
Introduction
Despite much evidence that cardiovascular disease outcome can be improved by lipid-lowering therapy (Sacks et al., 1996) , there is a remaining concern that lower cholesterol levels may affect mental health (Muldoon et al., 2001) . Community cohort studies and meta-analyses of randomized trials have found excess numbers of violent deaths among men receiving cholesterol-lowering therapy (Golomb, 1998) , and in large population enrolled in a health screening (Golomb et al., 2000) . In addition, the risks of depression (Rozzini et al., 1996) and suicide (Golier et al., 1995; Zureik et al., 1996; Kaplan et al., 1997; Sarchiapone et al., 2001; Kim et al., 2002) have been reported to be associated with low cholesterol levels.
To explain these findings, a hypothesis known as the cholesterol-serotonin hypothesis has been proposed; more specifically, decreased cholesterol levels cause serotonin neurotransmitter system dysfunction, which is linked to a variety of psychological diseases (Engelberg, 1992; Kaplan et al., 1994; Hillbrand et al., 2000) .
Of the wide variety of serotonin receptors (Buhot, 1997) , the 5-HT2A receptor has become the focus of attention because of the receptor's involvement in the action of atypical antipsychotic drugs (Nocjar et al., 2002) . Recently a single nucleotide polymorphism in exon 1 of the 5-HT2A receptor gene (HTR2A), the T102C polymorphism, was identified. The C allele of this polymorphism is known to be related to a variety of psychiatric disease (Du et al., 2000; Arias et al., 2001; Bjork et al., 2002; Levitan et al., 2002; Walitza et al., 2002) , suggesting that the T102C polymorphism is related to the function of 5-HT2A receptor.
Both cardiovascular diseases and psychiatric diseases are very important public healthcare issues. Because the suppression of $ The first two authors equally contributed to this work. *To whom correspondence should be addressed. Tel: 82-2-2072 Tel: 82-2- -2226 Fax: 82-2-766-8904 E-mail: hyosoo@snu.ac.kr cholesterol levels benefits patients that suffer from cardiovascular diseases but may increase psychiatric diseases theoretically, the relationship between cholesterol level and serotonergic activity needs to be clarified. In this case-controlled study, we investigated the association between the HTR2A gene T102C polymorphism and blood cholesterol levels.
Materials and Methods
Subjects Six hundred and forty six study subjects were recruited from inpatients admitted to Seoul National University Hospital Cardiovascular Center for the evaluation of chest pain, from 1997 to 1999. Routine history taking and physical examination were performed by qualified physicians at the outpatient clinic. Patients with a history of psychiatric diseases or mood problems were excluded. After informed consent had been obtained, diagnostic coronary angiography was performed and 10 ml of peripheral blood was drawn for DNA preparation. The diagnosis of coronary artery disease and variant angina was determined in accordance with AHA/ACC guidelines (Scanlon et al., 1999) . Clinical parameters were collected and analyzed by independent physicians unaware of the genotyping results. The study protocol was approved by the Institutional Review Board of Seoul National University Hospital.
Determination of genotypes Genomic DNA was prepared from peripheral blood mononuclear cells using phenol/chloroform extraction and ethanol precipitation. The genotypes were determined by polymerase chain reaction (PCR) and restriction enzyme digestion with MspI endonuclease. We followed previously described protocols (Arranz et al., 1996) . Briefly, PCR was performed using the following primers; sense primer 5'-TCT GCT ACA AGT TCT GGC TT -3' and antisense primer 5'-CTG CAG CTT TTT CTC TAG GG -3'. 40 pmol of each primer and 0.5 µg of genomic DNA were mixed with 0.2 mM dNTPs, 1.5 mM MgCl 2 , and 10 mM 0.2 U of Taq polymerase (Genenmed, Seoul, Korea) C for 2 h. Electrophoresis on 1.6% agarose gel with ethidium bromide allowed the identification of the undigested 342-bp sized PCR product, representing the T allele, and 126-bp and 216-bp sized PCR products, representing the C allele. Results were confirmed by repeating the genotyping of 15% of the DNA samples, randomly selected, by an independent investigator; 100% agreement was obtained.
Statistical methods Categorical variables were evaluated using the χ 2 test, and continuous variables by the Student's t-test. The observed genotype frequencies were compared with the expected under Hardy-Weinberg equilibrium values by χ 2 tests. Mean plasma lipid levels, age, the presence of diabetes, hypertension, and smoking were compared between male and females. The plasma concentrations of lipids were also compared between different genotypes using t-test. An analysis of the covariance was used to test the association between HDL-cholesterol and T102C polymorphism, controlling for age, gender, diabetes, hypertension, smoking, body mass index, and coronary artery disease. All analysis were performed using SPSS for windows version 11.5 (SPSS Inc, Chicago, USA), and statistical significance was accepted when the two-sided p-value was less than 0.05.
Results
Study population The baseline characteristics of the patients were summarized in Table 1 . Four hundred twenty eight men 218 women were enrolled for the study. Mean age, body mass index (BMI), the presence of diabetes were similar between men and women. There were a significantly higher percentage of smoker and coronary artery disease in men. Mean triglyceride was significantly higher in men than in women. Mean total cholesterol, LDL-cholesterol, and HDL cholesterol were significantly higher in women than in men. There was also a significantly higher percentage of hypertension in women (Table 1) . (Table 2) . When the genotype distribution was analyzed according to the clinical characteristics including age, diabetes, hypertension, smoking, body mass index (BMI), coronary artery disease (CAD), we found no significant associations between the T102C polymorphism and these clinical characteristics. There were also no associations between the genotypes and LDLcholesterol and triglyceride. However, we discovered that total cholesterol and HDL-cholesterol were significantly lower in the CC genotype when compared to the non-CC genotype (total cholesterol, 193.6 ± 35.0 versus 202.1 ± 45.5 mg/dL, p = 0.016; HDL-cholesterol, 42.7 ± 11.6 versus 46.3 ± 12.7 mg/dL, p = 0.004) ( Table 3) .
Next we analyzed men and women separately, because the lipid levels were significantly different between men and women. There was still no association between the polymorphism and clinical characteristics even the genotype distribution was analyzed separately in men and women (data not shown). However, the association between HDLcholesterol and the genotypes were significant both in men (44.5 ± 11.4 versus 41.6 ± 11.3 mg/dL, p = 0.038) and women (49.9 ± 14.2 versus 44.7 ± 12.1 mg/dL, p = 0.023). The association between total cholesterol and the genotypes were no longer significant in men (198.3 ± 38.6 versus 191.6 ± 37.5 mg/dL, p = 0.126), while the association in women remained significant (209.5 ± 56.2 versus 197.1 ± 29.8 mg/dL, p = 0.042) ( Table 4) .
Because the levels of LDL-cholesterol, a major non-HDLcholesterol, and triglyceride were not significantly different between genotypes, the difference of HDL-cholesterol between genotypes might lead to the difference of total cholesterol between genotypes. So the effect of CC genotype on HDL-cholesterol might explain our data. Therefore, we analyzed the effect of CC genotype on HDL-cholesterol. Univariate analysis for age, hypertension, sex, diabetes, smoking, body mass index, and coronary artery disease revealed no single factor that was significantly related to the HDL-cholesterol level. To exclude the effects of other factors, which might confound the relationship between T102C polymorphism and HDL-cholesterol, an analysis of covariance (ANCOVA) that controlled for age, hypertension, sex, diabetes, smoking, body mass index, and coronary artery disease was performed. The CC genotype was significantly associated with HDL-cholesterol levels (p<0.001), and explained the 7.9% variance in the HDL-cholesterol levels.
Discussion
Our study shows that a common polymorphism of the The numbers in parenthesis are the actual number of patients. The distribution of the genotypes was compatible with the Hardy-Weinberg equilibrium, and similar between men and women. The numbers in parenthesis are the actual number of patients. There was no association between T102C polymorphism and clinical characteristics. However, total cholesterol and HDL-cholesterol were significantly lower in the CC genotype when compared to the non-CC genotype. *: p<0.05: CC versus non-CC genotypes.
HTR2A serotonin receptor gene is associated with significantly lower HDL-cholesterol level. Our study excluded all patients on, or with a history of, lipid lowering therapy; thereby, excluding the possibility of lipid level modulation by lipid-lowering therapy. Also, there were no women on hormone replacement therapy. This association is independent of other clinical variables that potentially affect blood lipid levels.
To our knowledge, we identified the T102C polymorphism of HTR2A gene in Koreans for the first time. The frequency of C allele of HTR2A gene of Koreans (0.512) was similar to those of Japanese (0.46) and less common than those of Caucasians (0.69). Our data support previous reports on the variability of the HTR2A gene polymorphism in difference races (Bondy et al., 2000; Yu et al., 2004) . Whether the difference in the HDL-cholesterol level between difference races can be explained by the difference in T102C polymorphism is a much more complex issue, and extends beyond the scope of this article. However, along with data from previous studies on Caucasian and Japanese, our study shows that a different T102C polymorphism may partially contribute to the ethnic difference in the HDL-cholesterol level.
Controversy exists on whether T102C polymorphism is functional mutation, because it is a silent mutation, does not change the polypeptide sequence coded by the gene. However, The T102C polymorphism is known to be related to a variety of psychiatric disease (Du et al., 2000; Arias et al., 2001; Bjork et al., 2002; Levitan et al., 2002; Walitza et al., 2002) , and clinical studies including meta-analysis revealed that it is also related to the clinical responses to the two 5-HT2A receptor antagonists, clozapine and risperidone (Arranz et al., 1995; Arranz et al., 1998; Lane et al., 2002) . Furthermore, pathological study identified that HTR2A mRNA expression is decreased in the human brain cortex in C allele group (Polesskaya et al., 2002) . A recently published clinical study found that a lower HDL-cholesterol level is related to altered neuronal serotonergic activity (Buydens-Branchey et al., 2000) . These findings support our hypothesis that T102C polymorphism is functional and is related to lower cholesterol levels.
The major limitation of our study was that the results of our study may not be applicable to the general population, because the majority of our study subjects were coronary artery disease patients with heterogeneous diagnosis. However, no difference was observed in the distribution of genotype frequencies between the diagnosis groups, including the normal coronary angiography group.
In conclusion, our study shows that the CC genotype of the T102C polymorphism is significantly associated with a lower level of HDL-cholesterol in Korean. This is the first demonstration showing the potential relationship between the genetic polymorphism of serotonin receptor and the cholesterol levels. Our study also shows that Koreans, when compared to Caucasians, have a lower frequency of C allele of HT2RA T102C polymorphism, which demonstrates the frequency variation among different ethnic groups. In view of the importance of HDL-cholesterol in the public health, these suggested associations of HT2RA T102C polymorphism should be studied further in a larger population of patients. Lipid levels given as mean±standard deviation (mg/dL). When men and women are analyzed separately, there were no differences in total cholesterol levels in men. However, the levels of HDL-cholesterol were significantly lower in CC genotype both in men and women, respectively. *: p<0.05: CC versus non-CC genotypes.
